Title: PROCABIO A European initiative to develop tailored treatment of prostate cancer by biomarkers
1PROCABIOA European initiative to
developtailored treatment of prostate cancerby
biomarkers
2Objectives PROCABIO(Tailored treatment of
prostate cancer by biomarkers)
- Integrate biomarkers in updated and improved
model for indolent prostate cancer - Integrate biomarkers in development of guidelines
for efficient strategies for active surveillance - Deliver validated biomarker tools that are easily
applicable for high throughput use in clinical
and screening settings - Establish overall acceptance of active
surveillance as a treatment modality for indolent
prostate cancer
For more information, contact e.schenk-braat_at_erasm
usmc.nl
3PROCABIO THREE YEAR PLAN
Central biorepository of blood and urine
Active surveillance trial in 8 centers according
to PRIAS protocol with 3 years follow-up
Validation in blood, urine or tissue of proteomic
and genomic biomarkers discriminating indolent
and progressive PCa
Informing stakeholders on progress and outcome
active surveillance study biomarker
implementation
For more information, contact e.schenk-braat_at_erasm
usmc.nl
4PROCABIO consortium (18 partners)
- 11 clinical academic partners 5 commercial
partners - Erasmus MC (NL) Finland (2)
- Institute of Cancer Research (UK) France
- LHôpital Saint-Louis (FR) Germany
- Lund University (SE) US
- Milan National Cancer Institute (I)
- RUNMC (NL)
- University of Helsinki (FIN) 2 advisory partners
- University of Münster (GE) EORTC (BE)
- University of Sheffield (UK) Europa Uomo (BE)
- University of Tampere (FIN)
- University of Turku (FIN)
For more information, contact e.schenk-braat_at_erasm
usmc.nl
5PROCABIO contact details
PROCABIO coordinator PROCABIO project
manager Prof. dr. Chris Bangma Dr. Ellen
Schenk-Braat Erasmus MC Erasmus MC Department
of Urology Department of Urology Room
H1096 JNI, room Be362 T. 31-10-7033607 T.
31-10-7043674 F. 31-10-7035838 F.
31-10-7044661 h.j.vanalphen_at_erasmusmc.nl e.schenk
-braat_at_erasmusmc.nl
6Integrated European Approach to Prostate Cancer
7(No Transcript)